UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
84 hedge funds and large institutions have $42M invested in Unity Biotechnology in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 28 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
36% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 28
50% less capital invested
Capital invested by funds: $83.8M → $42M (-$41.7M)
67% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 18
Holders
84
Holding in Top 10
2
Calls
$1.08M
Puts
$269K
Top Buyers
| 1 | +$784K | |
| 2 | +$708K | |
| 3 | +$425K | |
| 4 |
Renaissance Technologies
New York
|
+$384K |
| 5 |
Two Sigma Investments
New York
|
+$312K |
Top Sellers
| 1 | -$5.14M | |
| 2 | -$1.37M | |
| 3 | -$1.25M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$655K |
| 5 |
Millennium Management
New York
|
-$500K |